As I mentioned in the "labeling" section, I am very concerned about some of the options put forward in FDA's Threshold Working Group draft paper.
In particular I'm disappointed in their failure to consider sensitization effects when developing options for deciding how much of an allergen needs to be present to require labeling.
[url="http://www.cfsan.fda.gov/~dms/alrgn.html"]http://www.cfsan.fda.gov/~dms/alrgn.html[/url]
It looks like the draft paper is open for comment through August 16, 2005, and there are hearings scheduled in Washington D.C. next week. Written submissions to the working group or requests for oral presentations at these hearing are due by this Friday (July 8).
Does anyone know of any efforts to coordinate comments/testimony? (or who I might talk with to find out?)
Thanks!
